Resultados de la búsqueda

19 items
  1. WMA warns against making essential anaesthetic a controlled drug

    06 Marzo 2015
    Other news

    Scheduling ketamine would restrict its availability worldwide, which  would lead to harmful impact on animal health and welfare, as well on public health. The World Medical Association is urging its 111 member associations to lobby their governments to oppose scheduling the anaesthetic agent Ketamine as a controlled drug.

  2. The ketamine controversy, continued

    Martin Jelsma
    06 Marzo 2015
    Opinion

    The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.

  3. CND decision to schedule ketamine would undermine WHO treaty mandate

    Martin Jelsma
    16 Febrero 2015
    Article

    The UN Commission considers to bring ketamine under the control of the 1971 Convention on Psychotropic Substances contrary to WHO recommendations. The 58th Session of the UN Commission on Narcotic Drugs (CND) in March 2015 has been asked to consider a Chinese proposal to place ketamine – an essential medicine used for anaesthesia – in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/81). Ketamine is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine under any of the 1971 treaty schedules will reduce its availability and further deepen the already acute crisis of global surgery.

  4. Fact Sheet on the Proposal to Discuss International Scheduling of Ketamine at the 58th CND

    14 Febrero 2015

    Ketamine is an essential medicine used for anaesthesia. It is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine will leave these populations with no alternative anaesthesia for essential surgery, and will further deepen the already acute crisis of global surgery.

  5. The concept of ‘drug harms’

    • Peter Cohen
    28 Diciembre 2010
    Paper

    In my view, perceived harms associated with drugs are vulnerable to so many restrictions on reliability and validity that, for the time being, a serious estimate of drug harm per drug is impossible. In my view, it is even invalid to associate harms to drugs alone. Drugs are used by humans, under individual, social and legal conditions, in certain purities and dosages. Whatever the 'effects' of drugs, harmful or not, they cannot be estimated or even discussed without associating the drug with a particular user or user culture. Drugs per se do not meaningfully exist.

  6. Drug harms in the UK

    • David J Nutt, Leslie A King, Lawrence D Phillips, on behalf of the Independent Scientific Committee on Drugs
    01 Noviembre 2010
    Paper

    To provide better guidance to policy makers in health, policing, and social care, the harms that drugs cause need to be properly assessed. This task is not easy because of the wide range of ways in which drugs can cause harm. This study undertook a review of drug harms with the multicriteria decision analysis (MCDA) approach. This technology has been used successfully to lend support to decision makers facing complex issues characterised by many, conflicting objectives.

  7. Politics and science in classifying the dangers of drugs

    • Robin Room, Dan I. Lubman
    01 Noviembre 2010

    There is a long history of psychoactive substances being regarded as dangerous and subsequently being banned or forbidden. Often the bans were introduced on substances new and unfamiliar to a society, which were viewed as more dangerous than substances which were well known and enculturated. With industrialisation and the globalisation brought by European empires, the growing availability of psychoactive substances was increasingly seen as a problem in the 1800s, setting off social and policy reactions – what we know as the temperance movement against alcohol,
    and initial UK legislation limiting the sale of ‘poisons’.

  8. Guidance on the WHO review of psychoactive substances for international control

    17 Diciembre 2009
    Paper

    The 1961 UN Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances, entrust the Expert Committee on Drug Dependence of the World Health Organization (WHO) with the responsibility of assessing substances for abuse liability in order to make recommendations on their control under the two aforementioned Conventions.

  9. TNI Expert Seminar on the Classification of Controlled Substances

    10 Diciembre 2009
    Report

    The classification of drugs has a profound impact on the lives and well-being of individuals across the world and where the classification is incorrect, people suffer unnecessarily. This is an issue that deserves greater public awareness and greater engagement with citizenry and that where such public awareness is in place it should be galvanised in order to work towards a new democratic answer to this difficult situation.

  10. Estimating drug harms: a risky business?

    • David Nutt
    01 Octubre 2009

    No one is suggesting that drugs are not harmful. The critical question is one of scale and degree. We need a full and open discussion of the evidence and a mature debate about what the drug laws are for - and whether they doing their job? In `Estimating drug harms: a risky business', Professor David Nutt, of Imperial College London argues that the relative harms of legal drugs such as alcohol and tobacco are greater than those of a number of illegal drugs, including cannabis, LSD and ecstasy.

  11. Risk assessment of new psychoactive substances

    30 Junio 2009
    Report

    The principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment. The risk assessment has regard to the health and social risks of the use of, manufacture of, and traffic in the new psychoactive substance, the involvement of organised crime and the possible consequences of control measures. The guidelines were finalised and adopted by the EMCDDA’s Scientific Committee in November 2008.

  12. Ranking van drugs

    • J.G.C. van Amsterdam, A. Opperhuizen, M.W.J. Koeter, L.A.G.J.M. van Aerts, W. van den Brink
    30 Junio 2009
    Report

    In its report Ranking of drugs: A comparison of the harmful effects of drugs, the National Institute for Public Health and the Environment (RIVM) has performed a risk assessment on the harmful effects of 17 drugs plus that of tobacco and alcohol. These 19 items were ranked according to their degree of harm.

  13. Risk assessment of khat use in the Netherlands

    • E.J.M. Pennings, A. Opperhuizen, J.G.C. van Amsterdam
    22 Agosto 2008
    Paper

    In preparing a decision about the legal status of khat in the Netherlands, the Dutch Minister of Health requested CAM (Coordination point Assessment and Monitoring new drugs) to assess the overall risk of khat in the Netherlands. The present paper is a redraft of a report which formed the scientific basis of the risk evaluation procedure (October 2007). This report reviews the scientific data about khat available in the international literature. In addition, the report contains some information specific for the Netherlands (prevalence, availability of khat and public order aspects).

  14. Cannabis: Classification and Public Health

    01 Abril 2008
    Report

    The Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

  15. MDMA (‘ecstasy’)

    01 Febrero 2008
    Report

    Due to its prevalence of use, MDMA is a significant public health issue. The Council believes that criminal justice measures will only have limited effect and strongly advises the promulgation of public health messages. It is of vital importance that issues of classification do not detract from messages concerning public health.

  16. Development of a rational scale to assess the harm of drugs of potential misuse

    • David Nutt, Leslie A King, William Saulsbury, Colin Blakemore
    24 Marzo 2007
    Paper

    Drug misuse and abuse are major health problems. Harmful drugs are regulated according to classification systems that purport to relate to the harms and risks of each drug. However, the methodology and processes underlying classification systems are generally neither specified nor transparent, which reduces confidence in their accuracy and undermines health education messages.

  17. Review of the UK’s Drugs Classification System

    • Crime, Drug Strategy Directorate
    01 Mayo 2006

    The UK system of classifying drugs according to their harmfulness has been in place since the introduction of the Misuse of Drugs Act in 1971. Over the past 35 years patterns of drug use have changed quite significantly, and recent debates about the classification of certain drugs, especially cannabis, have led to questions about the clarity of the current system and whether it remains fit for purpose.

     

  18. The global political economy of scheduling

    • William B. McAllister
    26 Febrero 2004
    Paper

    This article explains the international context of regulation to control addicting substances that gave rise to schedules. It discusses the impact of scheduling decisions on subsequent national drug control legislation and international drug control negotiations, highlighting how the creation of schedules introduced new incentives and rewards into calculations about the national/international commerce in drugs.

  19. Development of the Convention on Psychotropic Substances, 1971

    01 Julio 1989
    Paper

    The 196l Single Convention did not include so-called "psychotropic substances" such as amphetamines and barbiturates among the drugs controlled. The discussions on the scope of control were focused on plant-based drugs, such as cannabis, poppy cultivation, poppy straw, coca bush and coca leaves This document describes the development of an international instrument for the control of psychotropic substances.